AstraZeneca PLC (AZN) is a publicly traded Healthcare sector company. As of October 5, 2026, AZN trades at $155.14 with a market cap of $243.34B and a P/E ratio of 0.00. AZN moved -1.24% today. Year to date, AZN is -14.66%; over the trailing twelve months it is -6.22%. Its 52-week range spans $122.48 to $212.71. Analyst consensus is strong buy with an average price target of $210.77. Rallies surfaces AZN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
AstraZeneca PLC (AZN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. AZN moved -1.24% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $155.14 |
| Market Cap | $243.34B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.80% |
| 52-Week High | $212.71 |
| 52-Week Low | $122.48 |
| Volume | 620.64K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
17 analysts cover AZN: 0 strong buy, 15 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $210.77.